Hypouricemic effect of statins: Another pleiotropic benefit?

Journal of Thoracic and Cardiovascular Surgery

Volumn 139, Issue 5, 2010, Pages 1358-1359

  López Cuenca, Ángel ^a   Roldán, Vanessa ^b   Marín, Francisco ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b HOSPITAL MORALES MESEGUER   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ANGINA PECTORIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG MEGADOSE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HYPOURICEMIA; LETTER; PRIORITY JOURNAL; URIC ACID BLOOD LEVEL;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ARTERY BYPASS; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERURICEMIA; LIPIDS; PYRROLES; TIME FACTORS; TREATMENT OUTCOME; URIC ACID;

EID: 77950883722     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2009.08.063     Document Type: Letter

References (5)

1. Hillis G.S., Cuthbertson B.H., Gibson P.H., McNeilly J.D., Maclennan G.S., Jeffrey R.R., et al. Uric acid levels and outcome from coronary artery bypass grafting. J Thorac Cardiovasc Surg 138 (2009) 200-205
2. Kakafika A., Tsimihodimos V., and Elisaf M. Effect of atorvastatin on serum uric acid levels. Atherosclerosis 158 (2001) 255
3. Collard C.D., Body S.C., Shernan S.K., Wang S., and Mangano D.T. Multicenter Study of Perioperative Ischemia (MCSPI) Research Group, Inc; Ischemia Research and Education Foundation (IREF) Investigators. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 132 (2006) 392-400
4. Athyros V.G., Mikhailidis D.P., Liberopoulos E.N., Kakafika A.I., Karagiannis A., Papageorgiou A.A., et al. Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study. Nephrol Dial Transplant 22 (2007) 118-2
5. López-Cuenca A., Marín F., Roldán V., Climent V.E., Valdés M., and Lip G.Y. Effects of atorvastatin 80 mg daily on indices of matrix remodelling in 'high-risk' patients with ischemic heart disease. Int J Cardiol (2008 Aug 21) [Epub ahead of print.]